NCT02408315View on ClinicalTrials.gov

Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

December 31, 2021

Conditions
Pregnancy
Interventions
DRUG

misoprostol/placebo

buccal or vaginal routes of administration/ placebo to compare methods for efficacy and safety during induction.

Trial Locations (2)

46202

IU Health Methodist Hospital, Indianapolis

Sidney and Lois Eskenazi Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) | Biotech Hunter | Biotech Hunter